Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 201067
Company: MYLAN
Company: MYLAN
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
ISRADIPINE | ISRADIPINE | 5MG | TABLET, EXTENDED RELEASE;ORAL | Discontinued | None | No | No |
ISRADIPINE | ISRADIPINE | 10MG | TABLET, EXTENDED RELEASE;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
11/27/2015 | ORIG-1 | Approval | Not Applicable |
Label is not available on this site. |